Bragg Analytics
Redefining Health Screening
Painless. Remote. Insightful.
Bragg Analytics is developing a non-invasive, AI-driven health risk assessment platform. Using advanced X-ray diffraction and AI technology, we analyse nail and hair samples to evaluate potential health risks. Our remote, pain-free, and affordable platform provides rapid wellness risk insights – eliminating the need for blood tests or invasive procedures.
Currently in the R&D phase, we're working towards validating our technology for future clinical applications.
Why Today’s Diagnostics Are Failing Us
Modern healthcare diagnostics are often invasive, expensive, and slow. From mammograms and biopsies to blood tests and lumbar punctures, patients endure pain, delays, and significant anxiety. Results can take up to two weeks, while the discomfort and cost deter many from seeking early testing. These barriers contribute to late diagnoses, poorer outcomes, and mounting pressure on global healthcare systems.
There is an urgent need for health risk assessment tools that are accurate, scalable, and patient-friendly – and that’s exactly what Bragg delivers.
Adapted from Bianco, Vittorio et al. Computational and Structural Biotechnology Journal, Volume 24, 225 - 236
Non-Invasive, Fast, and Scalable Health Risk Screening
Bragg Analytics replaces invasive testing with a dry-lab, mail-in model using keratin samples (nails and hair). Our technology combines advanced X-ray diffraction (XRD and XRF) with AI to identify structural and biochemical markers associated with potential health risks.
We deliver remote, pain-free risk insights within minutes.
Gentle Process
The method is painless and non-invasive, ensuring patient comfort and ease.
Affordable Scalability
The system is designed to be low-cost and easily scalable for widespread use
Mail Kits
Samples can be collected from home using mail-in kits—no clinic visits required.
Broad Utility
Effective at evaluating risk factors for cancer, diabetes, and neurodegenerative diseases.
AI Risk Evaluation
Results are analyzed with advanced AI and delivered online, highlighting potential health risks
How it works?
Advanced X-ray and AI Technology
Our platform is built on decades of research in X-ray crystallography and compositional analysis. Bragg Analytics uses AI to interpret complex X-ray diffraction and fluorescence data from keratin samples. Our approach removes the need for wet labs, enabling a more efficient, accessible, and capital-light approach to health risk assessment.
What sets us apart:
Market Pioneer
As the first to introduce keratin-based diagnostics, we hold a powerful first-mover advantage that positions us uniquely to shape and lead this emerging field before competitors enter.
Strong Patents
Our robust and expanding intellectual property portfolio safeguards our innovations, strengthens our competitive edge, and provides long-term stability as we scale and evolve the health risk assessment technology.
Unique Offering
There are currently no direct competitors delivering this model of diagnostic testing, giving us an uncontested space to innovate, refine, and build brand leadership without market saturation.
Further Details
To explore the underlying science and technology in greater depth, visit Vitacrystallography for comprehensive technical documentation, research foundations, and our preventive health analytics framework’s key differentiators.
Team
Our leadership team brings deep experience in diagnostics, AI, and medical innovation. We are also supported by a growing network of clinical, scientific, and technical experts.
Contact Us
We believe in a future where health risk evaluation is effortless, accessible, and driven by science. Whether you’re an investor, partner, or potential user, we’d love to hear from you.